HomeIMVT • NASDAQ
Immunovant Inc
add
$16.12
3.47%
Pre-market:(0.74%)-0.12
$16.00
Closed: Sep 5, 12:17:33 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 127.22M | 34.94% |
Net income | -120.61M | -38.40% |
Net profit margin | — | — |
Earnings per share | -0.71 | -18.33% |
EBITDA | -127.12M | -34.94% |
Effective tax rate | -0.76% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 598.91M | 6.95% |
Total assets | 661.44M | 12.17% |
Total liabilities | 52.90M | 17.51% |
Total equity | 608.54M | — |
Shares outstanding | 174.32M | — |
Price to book | 4.69 | — |
Return on assets | -44.25% | — |
Return on capital | -48.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -120.61M | -38.40% |
Cash from operations | -117.41M | -54.08% |
Cash from investing | — | — |
Cash from financing | 2.92M | 325.36% |
Net change in cash | -115.06M | -52.68% |
Free cash flow | -75.84M | -58.88% |
Previous close
$16.70
Day range
$16.07 - $16.74
Year range
$12.72 - $34.47
Market cap
2.81B USD
Avg Volume
1.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Website
Employees
362
